$4.8 Billion is the total value of Avidity Partners Management LP's 92 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 46.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | SPDR SER TRcall | $296,604,000 | – | 3,300,000 | +100.0% | 6.18% | – | |
AZN | Buy | ASTRAZENECA PLCsponsored adr | $245,458,000 | +47.0% | 3,700,000 | +29.0% | 5.11% | +44.3% |
ABBV | Sell | ABBVIE INC | $237,669,000 | -11.6% | 1,466,100 | -26.1% | 4.95% | -13.2% |
ANTM | Buy | ANTHEM INC | $196,193,000 | +31.9% | 399,400 | +24.4% | 4.08% | +29.4% |
ARVN | Buy | ARVINAS INC | $196,200,000 | -5.5% | 2,915,300 | +15.3% | 4.08% | -7.2% |
MRK | New | MERCK & CO INC | $194,459,000 | – | 2,370,000 | +100.0% | 4.05% | – |
AVTR | Buy | AVANTOR INC | $191,702,000 | -5.1% | 5,668,300 | +18.3% | 3.99% | -6.8% |
BAX | Buy | BAXTER INTL INC | $148,528,000 | -2.0% | 1,915,500 | +8.5% | 3.09% | -3.7% |
ZNTL | Buy | ZENTALIS PHARMACEUTICALS INC | $146,587,000 | -35.8% | 3,176,999 | +17.0% | 3.05% | -36.9% |
BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $145,960,000 | -7.1% | 1,231,000 | +8.0% | 3.04% | -8.8% |
VRTX | Buy | VERTEX PHARMACEUTICALS | $142,385,000 | +131.6% | 545,600 | +94.9% | 2.96% | +127.4% |
UNH | Buy | UNITEDHEALTH GROUP INC | $132,388,000 | +114.2% | 259,600 | +110.9% | 2.76% | +110.3% |
UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $128,986,000 | +11.6% | 718,946 | +34.4% | 2.69% | +9.5% |
HZNP | Buy | HORIZON THERAPEUTICS PUB L | $119,035,000 | +9.2% | 1,131,400 | +11.8% | 2.48% | +7.2% |
MRTX | Buy | MIRATI THERAPEUTICS INC | $114,532,000 | -3.2% | 1,393,000 | +72.7% | 2.38% | -4.9% |
ISEE | Sell | IVERIC BIO INC | $108,981,000 | -6.3% | 6,475,400 | -6.9% | 2.27% | -8.0% |
NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $108,750,000 | +1.3% | 1,160,000 | -7.9% | 2.26% | -0.5% |
IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $100,620,000 | +39.4% | 6,043,219 | +59.9% | 2.10% | +36.9% |
ISRG | New | INTUITIVE SURGICAL INC | $98,046,000 | – | 325,000 | +100.0% | 2.04% | – |
CTLT | Buy | CATALENT INC | $86,724,000 | -2.5% | 782,000 | +12.5% | 1.81% | -4.3% |
HUM | New | HUMANA INC | $86,555,000 | – | 198,900 | +100.0% | 1.80% | – |
SNDX | SYNDAX PHARMACEUTICALS INC | $83,831,000 | -20.6% | 4,823,400 | 0.0% | 1.75% | -22.0% | |
BIIB | New | BIOGEN INC | $76,869,000 | – | 365,000 | +100.0% | 1.60% | – |
RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $63,107,000 | +7.2% | 869,000 | +24.1% | 1.31% | +5.3% |
JNJ | New | JOHNSON & JOHNSON | $62,739,000 | – | 354,000 | +100.0% | 1.31% | – |
ACET | Buy | ADICET BIO INC | $62,306,000 | +17.4% | 3,120,000 | +2.8% | 1.30% | +15.3% |
KZR | Buy | KEZAR LIFE SCIENCES INC | $58,469,000 | +8.3% | 3,518,000 | +9.0% | 1.22% | +6.3% |
MCK | New | MCKESSON CORP | $58,012,000 | – | 189,500 | +100.0% | 1.21% | – |
ARGX | New | ARGENX SEsponsored adr | $55,495,000 | – | 176,000 | +100.0% | 1.16% | – |
BSX | New | BOSTON SCIENTIFIC CORP | $52,975,000 | – | 1,196,100 | +100.0% | 1.10% | – |
NTRA | Buy | NATERA INC | $52,884,000 | -39.8% | 1,300,000 | +38.3% | 1.10% | -40.9% |
EW | New | EDWARDS LIFESCIENCES CORP | $51,797,000 | – | 440,000 | +100.0% | 1.08% | – |
ARWR | Buy | ARROWHEAD PHARMACEUTICALS IN | $43,920,000 | -24.3% | 955,000 | +9.1% | 0.91% | -25.7% |
IMCR | Buy | IMMUNOCORE HLDGS PLCads | $40,778,000 | -3.2% | 1,363,800 | +10.9% | 0.85% | -4.9% |
LEGN | Buy | LEGEND BIOTECH CORPsponsored ads | $39,792,000 | +19.9% | 1,095,000 | +53.8% | 0.83% | +17.8% |
XBI | New | SPDR SER TRs&p biotech | $39,547,000 | – | 440,000 | +100.0% | 0.82% | – |
BHC | New | BAUSCH HEALTH COS INC | $38,724,000 | – | 1,694,700 | +100.0% | 0.81% | – |
RNA | Buy | AVIDITY BIOSCIENCES INC | $37,771,000 | -12.5% | 2,045,000 | +12.7% | 0.79% | -14.1% |
INSM | Sell | INSMED INC | $31,832,000 | -19.4% | 1,354,539 | -6.6% | 0.66% | -20.9% |
ATEC | Sell | ALPHATEC HLDGS INC | $31,459,000 | -0.7% | 2,735,600 | -1.3% | 0.66% | -2.5% |
IDYA | Buy | IDEAYA BIOSCIENCES INC | $30,101,000 | -50.1% | 2,690,000 | +5.4% | 0.63% | -51.0% |
AXSM | Sell | AXSOME THERAPEUTICS INC | $29,428,000 | +0.5% | 711,000 | -8.3% | 0.61% | -1.3% |
CCXI | Buy | CHEMOCENTRYX INC | $29,457,000 | +25.5% | 1,175,000 | +82.3% | 0.61% | +23.1% |
RCUS | New | ARCUS BIOSCIENCES INC | $28,783,000 | – | 912,000 | +100.0% | 0.60% | – |
NTLA | New | INTELLIA THERAPEUTICS INC | $28,347,000 | – | 390,075 | +100.0% | 0.59% | – |
PHAT | Buy | PHATHOM PHARMACEUTICALS INC | $26,485,000 | -29.0% | 1,946,000 | +2.6% | 0.55% | -30.3% |
Buy | CARIBOU BIOSCIENCES INC | $25,879,000 | -35.9% | 2,819,067 | +5.4% | 0.54% | -37.0% | |
NUVB | Sell | NUVATION BIO INC | $25,537,000 | -59.3% | 4,855,006 | -34.2% | 0.53% | -60.0% |
BLU | Sell | BELLUS HEALTH INC NEW | $25,353,000 | -16.6% | 3,685,000 | -2.4% | 0.53% | -18.1% |
SPNE | SEASPINE HLDGS CORP | $24,442,000 | -10.7% | 2,010,000 | 0.0% | 0.51% | -12.4% | |
PEN | New | PENUMBRA INC | $23,102,000 | – | 104,000 | +100.0% | 0.48% | – |
SIBN | Buy | SI-BONE INC | $22,600,000 | +3.1% | 1,000,000 | +1.3% | 0.47% | +1.3% |
VIR | Buy | VIR BIOTECHNOLOGY INC | $20,062,000 | -31.6% | 780,000 | +11.4% | 0.42% | -32.8% |
VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $19,230,000 | -23.9% | 1,040,000 | -18.6% | 0.40% | -25.4% |
BPMC | Sell | BLUEPRINT MEDICINES CORP | $18,601,000 | -82.5% | 291,184 | -70.7% | 0.39% | -82.9% |
ALT | Buy | ALTIMMUNE INC | $17,448,000 | -31.1% | 2,865,000 | +3.6% | 0.36% | -32.4% |
EPIX | ESSA PHARMA INC | $15,203,000 | -56.5% | 2,460,000 | 0.0% | 0.32% | -57.2% | |
SGEN | Sell | SEAGEN INC | $14,405,000 | -86.4% | 100,000 | -85.4% | 0.30% | -86.6% |
GLPG | New | GALAPAGOS NVspon adr | $13,334,000 | – | 215,000 | +100.0% | 0.28% | – |
IPSC | Buy | CENTURY THERAPEUTICS INC | $10,890,000 | -19.4% | 865,000 | +1.6% | 0.23% | -20.6% |
ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $10,827,000 | -41.9% | 1,207,000 | -10.3% | 0.22% | -43.0% |
APLS | New | APELLIS PHARMACEUTICALS INC | $10,670,000 | – | 210,000 | +100.0% | 0.22% | – |
New | AN2 THERAPEUTICS INC | $10,373,000 | – | 688,330 | +100.0% | 0.22% | – | |
New | ERASCA INC | $8,557,000 | – | 995,000 | +100.0% | 0.18% | – | |
S | Sell | SENTINELONE INCcl a | $7,922,000 | -24.6% | 204,500 | -1.7% | 0.16% | -26.0% |
CYT | Buy | CYTEIR THERAPEUTICS INC | $6,975,000 | -66.8% | 1,850,000 | +0.0% | 0.14% | -67.5% |
PHAS | PHASEBIO PHARMACEUTICALS INC | $5,815,000 | -49.4% | 4,405,000 | 0.0% | 0.12% | -50.4% | |
CMAX | Sell | CAREMAX INC | $5,642,000 | -11.2% | 755,329 | -8.7% | 0.12% | -13.3% |
Buy | TANGO THERAPEUTICS INC | $5,465,000 | -29.1% | 721,000 | +2.3% | 0.11% | -30.5% | |
Sell | HYPERFINE INC | $5,323,000 | -51.5% | 1,503,754 | -0.7% | 0.11% | -52.4% | |
MSAC | MEDICUS SCIENCES ACQUISITION | $5,086,000 | +0.9% | 520,000 | 0.0% | 0.11% | -0.9% | |
BLSA | BCLS ACQUISITION CORP | $4,935,000 | +0.7% | 500,000 | 0.0% | 0.10% | -1.0% | |
DYNS | DYNAMICS SPECIAL PURPOSE COR | $4,935,000 | +0.1% | 500,000 | 0.0% | 0.10% | -1.9% | |
ARYD | ARYA SCIENCES ACQU CORP IVcl a | $4,900,000 | -1.2% | 500,000 | 0.0% | 0.10% | -2.9% | |
PANA | PANACEA ACQUISITION CORP II | $4,875,000 | +0.5% | 500,000 | 0.0% | 0.10% | -1.0% | |
HLXA | HELIX ACQUISITION CORP | $4,440,000 | +12.2% | 400,000 | 0.0% | 0.09% | +9.5% | |
HSAQ | HEALTH SCIENCES ACQ CORP 2 | $3,964,000 | -1.7% | 400,000 | 0.0% | 0.08% | -3.5% | |
Sell | FIELD TRIP HEALTH LTD | $3,988,000 | -49.4% | 2,976,000 | -7.1% | 0.08% | -50.3% | |
GRPH | GRAPHITE BIO INC | $3,621,000 | -59.0% | 710,000 | 0.0% | 0.08% | -59.9% | |
ONCS | ONCOSEC MED INC | $3,387,000 | +19.9% | 2,945,000 | 0.0% | 0.07% | +18.3% | |
OTIC | New | OTONOMY INC | $3,240,000 | – | 1,349,905 | +100.0% | 0.07% | – |
SEMA4 HOLDINGS CORP | $2,917,000 | -31.2% | 950,000 | 0.0% | 0.06% | -32.2% | ||
CMPX | COMPASS THERAPEUTICS INC | $2,740,000 | -56.8% | 2,000,000 | 0.0% | 0.06% | -57.5% | |
GRTS | Sell | GRITSTONE BIO INC | $2,307,000 | -95.9% | 560,000 | -87.2% | 0.05% | -96.0% |
Buy | SCIENCE 37 HOLDINGS INC | $2,301,000 | -53.2% | 430,000 | +9.1% | 0.05% | -53.8% | |
SCYX | Sell | SCYNEXIS INC | $2,127,000 | -84.4% | 544,043 | -75.7% | 0.04% | -84.8% |
DNAA | SOCIAL CAP SUVRETTA HLDS CRP | $1,978,000 | -0.4% | 200,000 | 0.0% | 0.04% | -2.4% | |
DNAB | SOCIAL CAP SUVRETTA HLDS CRP | $1,950,000 | -1.4% | 200,000 | 0.0% | 0.04% | -2.4% | |
DNAC | SOCIAL CAP SUVRETTA HLD CRPI | $1,980,000 | 0.0% | 200,000 | 0.0% | 0.04% | -2.4% | |
DNAD | SOCIAL CAP SUVRETTA HLDS CP | $1,948,000 | -0.8% | 200,000 | 0.0% | 0.04% | -2.4% | |
NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $76,000 | -59.8% | 99,999 | 0.0% | 0.00% | -50.0% | |
MSACW | MEDICUS SCIENCES ACQUISITION*w exp 02/12/202 | $25,000 | -40.5% | 57,770 | 0.0% | 0.00% | 0.0% | |
Exit | SOMALOGIC INC*w exp 08/31/202 | $0 | – | -65,999 | -100.0% | -0.01% | – | |
ZIOP | Exit | ZIOPHARM ONCOLOGY INC | $0 | – | -590,000 | -100.0% | -0.01% | – |
STTK | Exit | SHATTUCK LABS INC | $0 | – | -165,000 | -100.0% | -0.03% | – |
MRUS | Exit | MERUS N V | $0 | – | -103,000 | -100.0% | -0.07% | – |
Exit | SOMALOGIC INC | $0 | – | -330,000 | -100.0% | -0.08% | – | |
Exit | ENTRADA THERAPEUTICS INC | $0 | – | -255,000 | -100.0% | -0.09% | – | |
HOWL | Exit | WEREWOLF THERAPEUTICS INC | $0 | – | -485,000 | -100.0% | -0.12% | – |
GLUE | Exit | MONTE ROSA THERAPEUTICS INC | $0 | – | -300,000 | -100.0% | -0.13% | – |
Exit | EQRX INC | $0 | – | -1,000,000 | -100.0% | -0.14% | – | |
Exit | DEFINITIVE HEALTHCARE CORP | $0 | – | -250,000 | -100.0% | -0.14% | – | |
TALS | Exit | TALARIS THERAPEUTICS INC | $0 | – | -455,037 | -100.0% | -0.15% | – |
TIL | Exit | INSTIL BIO INC | $0 | – | -408,140 | -100.0% | -0.15% | – |
ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -300,000 | -100.0% | -0.15% | – |
RLMD | Exit | RELMADA THERAPEUTICS INC | $0 | – | -731,536 | -100.0% | -0.35% | – |
GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -862,000 | -100.0% | -0.54% | – |
AMN | Exit | AMN HEALTHCARE SVCS INC | $0 | – | -280,100 | -100.0% | -0.73% | – |
OCDX | Exit | ORTHO CLINICAL DIAGNOSTICS H | $0 | – | -1,790,000 | -100.0% | -0.81% | – |
KYMR | Exit | KYMERA THERAPEUTICS INC | $0 | – | -670,000 | -100.0% | -0.90% | – |
Exit | STEVANATO GROUP S P A | $0 | – | -2,541,893 | -100.0% | -1.21% | – | |
ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -370,000 | -100.0% | -1.33% | – |
SHC | Exit | SOTERA HEALTH CO | $0 | – | -2,960,000 | -100.0% | -1.48% | – |
HOLX | Exit | HOLOGIC INC | $0 | – | -1,064,000 | -100.0% | -1.73% | – |
LLY | Exit | LILLY ELI & CO | $0 | – | -344,800 | -100.0% | -2.02% | – |
ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -1,215,500 | -100.0% | -2.40% | – |
PFE | Exit | PFIZER INC | $0 | – | -2,090,000 | -100.0% | -2.62% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NEUROCRINE BIOSCIENCES INC | 15 | Q3 2023 | 4.6% |
ARVINAS INC | 14 | Q3 2023 | 4.9% |
ZENTALIS PHARMACEUTICALS INC | 14 | Q3 2023 | 4.8% |
SYNDAX PHARMACEUTICALS INC | 14 | Q3 2023 | 3.2% |
IDEAYA BIOSCIENCES INC | 13 | Q3 2023 | 2.5% |
NATERA INC | 13 | Q3 2023 | 1.9% |
ALPINE IMMUNE SCIENCES INC | 13 | Q3 2023 | 0.5% |
ABBVIE INC | 12 | Q2 2023 | 9.7% |
HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 3.4% |
AVANTOR INC | 11 | Q1 2023 | 6.0% |
View Avidity Partners Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Adicet Bio, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
ALPINE IMMUNE SCIENCES, INC. | February 14, 2023 | 1,888,887 | 4.0% |
ESSA Pharma Inc. | February 14, 2023 | 1,855,400 | 4.2% |
Gritstone bio, Inc. | February 14, 2023 | 2,859,971 | 3.3% |
IVERIC bio, Inc. | February 14, 2023 | 838,407 | 0.6% |
ONCOSEC MEDICAL IncSold out | February 14, 2023 | 0 | 0.0% |
PhaseBio Pharmaceuticals Inc | February 14, 2023 | 2,040,000 | 4.1% |
Phathom Pharmaceuticals, Inc. | February 14, 2023 | 1,900,000 | 4.6% |
Viridian Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Anika Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Avidity Partners Management LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G | 2024-03-27 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
View Avidity Partners Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.